Elon Musk got angry at Bill Gates for blaming him over aid cuts. Musk hit back by bringing up Gate’s past links to Epstein, and the two bil...

A Lancet report warns that suspending or limiting funding to PEPFAR could lead to dire consequences in the African region. By 2030, one mil...

Bill Gates has been actively lobbying Trump administration officials to maintain funding for global health programs, including childhood va...

US Secretary of State Marco Rubio announced exemptions in the freeze on foreign assistance, continuing funding for humanitarian items like ...

Cipla, a drugmaker involved in supplying HIV medications through US-supported programmes, anticipates minimal impact from the Trump adminis...

U.S.-funded aid programs globally face halts and layoffs as a significant freeze on foreign assistance and domestic federal grants by the T...

Laurus Labs reported a 7% YoY drop in API revenues to Rs 531 crore for Q3 FY24, driven by lower ARV volumes. However, the FDF segment saw A...

The United States, led by Secretary of State Marco Rubio under President Donald Trump's new "America First" policy, has frozen nearly all f...

New annual HIV infections in India have decreased by 44 per cent since 2010, surpassing the global reduction rate of 39 per cent. Union Min...

Strides Pharma Global, a subsidiary of Strides Pharma Science, has received tentative approval from the US FDA for its generic Dolutegravir...

Through the MPP-ViiV Healthcare agreement, the three generic manufacturers will be able to develop, manufacture, and supply generic version...

"The United States of America will remain the global leader in the fight against HIV and AIDS," Obama said.

Shares of domestic pharma major Ranbaxy Laboratories today touched a 52-week low of Rs 250.50 with analysts saying that it is the effect of...

The outlook doesn’t look the least encouraging for Indian markets with Asian stocks falling for a fourth day after the US financial rescue ...

US government will not source drugs under its global AIDS drug supply programme from Ranbaxy plants in India. Top food myths| Successful bi...

The development follows the US Food and Drug Administration’s (USFDA) ban on Ranbaxy’s 30 generic drugs and seven APIs.

Aurobindo Pharma, Cipla and Ranbaxy, have received a lion's share of over 85 per cent in the US government's latest fiscal funding for AIDS...